CarbinoxaMine Maleate (CAS No 3505-38-2) is an antihistamine often studied in biomedical research for its role in allergy and respiratory studies Originating from first-generation antihistamines it primarily targets H1 histamine receptors inhibiting the action of histamine in allergic reactions Its mechanism of action involves blocking the receptors reducing symptoms like itching swelling and runny noses In vitro studies frequently show activity in the nanomolar to low micromolar range demonstrating its potency in these controlled settings Common applications of CarbinoxaMine Maleate include use in cell models to evaluate histamine-related responses animal studies for allergy and inflammation research and drug screening to assess antihistamine candidates Experimental concentrations typically depend on the specific research design allowing flexibility based on the study s objectives and requirements